Insulin therapy in the pediatric intensive care unit

Sascha C.A.T. Verbruggen, Koen F.M. Joosten, Leticia Castillo, Johannes B. van Goudoever

Research output: Contribution to journalReview article

35 Citations (Scopus)

Abstract

Background & aims: Hyperglycemia is a major risk factor for increased morbidity and mortality in the intensive care unit. Insulin therapy has emerged in adult intensive care units and several pediatric studies are currently being conducted. This review discusses hyperglycemia and the effects of insulin on metabolic and non-metabolic pathways, with a focus on pediatric critical illness. Methods: A PubMed search was performed by using the following keywords and limits (("hyperglycemia"[MeSH terms] or ("insulin resistance"[MeSH major topic]) and ("critical care"[MeSH terms] or "critical illness"[MeSH terms])) in different combinations with ("metabolism"[MeSH terms] or "metabolic networks and pathways"[MeSH terms]) and ("outcome"[all fields]) and ("infant"[MeSH terms] or "child"[MeSH terms] or "adolescent"[MeSH terms]). Quality assessment of selected studies included clinical pertinence, publication in peer-reviewed journals, objectivity of measurements and techniques used to minimize bias. Reference lists of such studies were included. Results: The magnitude and duration of hyperglycemia are associated with increased morbidity and mortality in the pediatric intensive care unit (PICU), but prospective, randomized controlled studies with insulin therapy have not been published yet. Evidence concerning the mechanism and the effect of insulin on glucose and lipid metabolism in pediatric critical illness is scarce. More is known about the positive effect on protein homeostasis, especially in severely burned children. The effect in septic children is less clear and seems age dependent. Some non-metabolic properties of insulin such as the modulation of inflammation, endothelial dysfunction and coagulopathy have not been fully investigated in children. Conclusion: Future studies on the effect of insulin on morbidity and mortality as well as on the mechanisms through which insulin exerts these effects are necessary in critically ill children. We propose these studies to be conducted under standardized conditions including precise definitions of hyperglycemia and rates of glucose intake.

Original languageEnglish (US)
Pages (from-to)677-690
Number of pages14
JournalClinical Nutrition
Volume26
Issue number6
DOIs
StatePublished - Dec 1 2007
Externally publishedYes

Fingerprint

Pediatric Intensive Care Units
Insulin
Hyperglycemia
Critical Illness
Morbidity
Therapeutics
Mortality
Pediatrics
Glucose
Critical Care
Metabolic Networks and Pathways
Lipid Metabolism
PubMed
Intensive Care Units
Insulin Resistance
Publications
Homeostasis
Inflammation

Keywords

  • Catabolism
  • Critical illness
  • Endothelium
  • Hyperglycemia
  • Inflammation
  • Metabolism
  • Pediatrics

ASJC Scopus subject areas

  • Nutrition and Dietetics
  • Critical Care and Intensive Care Medicine

Cite this

Verbruggen, S. C. A. T., Joosten, K. F. M., Castillo, L., & van Goudoever, J. B. (2007). Insulin therapy in the pediatric intensive care unit. Clinical Nutrition, 26(6), 677-690. https://doi.org/10.1016/j.clnu.2007.08.012

Insulin therapy in the pediatric intensive care unit. / Verbruggen, Sascha C.A.T.; Joosten, Koen F.M.; Castillo, Leticia; van Goudoever, Johannes B.

In: Clinical Nutrition, Vol. 26, No. 6, 01.12.2007, p. 677-690.

Research output: Contribution to journalReview article

Verbruggen, SCAT, Joosten, KFM, Castillo, L & van Goudoever, JB 2007, 'Insulin therapy in the pediatric intensive care unit', Clinical Nutrition, vol. 26, no. 6, pp. 677-690. https://doi.org/10.1016/j.clnu.2007.08.012
Verbruggen, Sascha C.A.T. ; Joosten, Koen F.M. ; Castillo, Leticia ; van Goudoever, Johannes B. / Insulin therapy in the pediatric intensive care unit. In: Clinical Nutrition. 2007 ; Vol. 26, No. 6. pp. 677-690.
@article{9b23301de2c348a180444f518ab47449,
title = "Insulin therapy in the pediatric intensive care unit",
abstract = "Background & aims: Hyperglycemia is a major risk factor for increased morbidity and mortality in the intensive care unit. Insulin therapy has emerged in adult intensive care units and several pediatric studies are currently being conducted. This review discusses hyperglycemia and the effects of insulin on metabolic and non-metabolic pathways, with a focus on pediatric critical illness. Methods: A PubMed search was performed by using the following keywords and limits (({"}hyperglycemia{"}[MeSH terms] or ({"}insulin resistance{"}[MeSH major topic]) and ({"}critical care{"}[MeSH terms] or {"}critical illness{"}[MeSH terms])) in different combinations with ({"}metabolism{"}[MeSH terms] or {"}metabolic networks and pathways{"}[MeSH terms]) and ({"}outcome{"}[all fields]) and ({"}infant{"}[MeSH terms] or {"}child{"}[MeSH terms] or {"}adolescent{"}[MeSH terms]). Quality assessment of selected studies included clinical pertinence, publication in peer-reviewed journals, objectivity of measurements and techniques used to minimize bias. Reference lists of such studies were included. Results: The magnitude and duration of hyperglycemia are associated with increased morbidity and mortality in the pediatric intensive care unit (PICU), but prospective, randomized controlled studies with insulin therapy have not been published yet. Evidence concerning the mechanism and the effect of insulin on glucose and lipid metabolism in pediatric critical illness is scarce. More is known about the positive effect on protein homeostasis, especially in severely burned children. The effect in septic children is less clear and seems age dependent. Some non-metabolic properties of insulin such as the modulation of inflammation, endothelial dysfunction and coagulopathy have not been fully investigated in children. Conclusion: Future studies on the effect of insulin on morbidity and mortality as well as on the mechanisms through which insulin exerts these effects are necessary in critically ill children. We propose these studies to be conducted under standardized conditions including precise definitions of hyperglycemia and rates of glucose intake.",
keywords = "Catabolism, Critical illness, Endothelium, Hyperglycemia, Inflammation, Metabolism, Pediatrics",
author = "Verbruggen, {Sascha C.A.T.} and Joosten, {Koen F.M.} and Leticia Castillo and {van Goudoever}, {Johannes B.}",
year = "2007",
month = "12",
day = "1",
doi = "10.1016/j.clnu.2007.08.012",
language = "English (US)",
volume = "26",
pages = "677--690",
journal = "Clinical Nutrition",
issn = "0261-5614",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - Insulin therapy in the pediatric intensive care unit

AU - Verbruggen, Sascha C.A.T.

AU - Joosten, Koen F.M.

AU - Castillo, Leticia

AU - van Goudoever, Johannes B.

PY - 2007/12/1

Y1 - 2007/12/1

N2 - Background & aims: Hyperglycemia is a major risk factor for increased morbidity and mortality in the intensive care unit. Insulin therapy has emerged in adult intensive care units and several pediatric studies are currently being conducted. This review discusses hyperglycemia and the effects of insulin on metabolic and non-metabolic pathways, with a focus on pediatric critical illness. Methods: A PubMed search was performed by using the following keywords and limits (("hyperglycemia"[MeSH terms] or ("insulin resistance"[MeSH major topic]) and ("critical care"[MeSH terms] or "critical illness"[MeSH terms])) in different combinations with ("metabolism"[MeSH terms] or "metabolic networks and pathways"[MeSH terms]) and ("outcome"[all fields]) and ("infant"[MeSH terms] or "child"[MeSH terms] or "adolescent"[MeSH terms]). Quality assessment of selected studies included clinical pertinence, publication in peer-reviewed journals, objectivity of measurements and techniques used to minimize bias. Reference lists of such studies were included. Results: The magnitude and duration of hyperglycemia are associated with increased morbidity and mortality in the pediatric intensive care unit (PICU), but prospective, randomized controlled studies with insulin therapy have not been published yet. Evidence concerning the mechanism and the effect of insulin on glucose and lipid metabolism in pediatric critical illness is scarce. More is known about the positive effect on protein homeostasis, especially in severely burned children. The effect in septic children is less clear and seems age dependent. Some non-metabolic properties of insulin such as the modulation of inflammation, endothelial dysfunction and coagulopathy have not been fully investigated in children. Conclusion: Future studies on the effect of insulin on morbidity and mortality as well as on the mechanisms through which insulin exerts these effects are necessary in critically ill children. We propose these studies to be conducted under standardized conditions including precise definitions of hyperglycemia and rates of glucose intake.

AB - Background & aims: Hyperglycemia is a major risk factor for increased morbidity and mortality in the intensive care unit. Insulin therapy has emerged in adult intensive care units and several pediatric studies are currently being conducted. This review discusses hyperglycemia and the effects of insulin on metabolic and non-metabolic pathways, with a focus on pediatric critical illness. Methods: A PubMed search was performed by using the following keywords and limits (("hyperglycemia"[MeSH terms] or ("insulin resistance"[MeSH major topic]) and ("critical care"[MeSH terms] or "critical illness"[MeSH terms])) in different combinations with ("metabolism"[MeSH terms] or "metabolic networks and pathways"[MeSH terms]) and ("outcome"[all fields]) and ("infant"[MeSH terms] or "child"[MeSH terms] or "adolescent"[MeSH terms]). Quality assessment of selected studies included clinical pertinence, publication in peer-reviewed journals, objectivity of measurements and techniques used to minimize bias. Reference lists of such studies were included. Results: The magnitude and duration of hyperglycemia are associated with increased morbidity and mortality in the pediatric intensive care unit (PICU), but prospective, randomized controlled studies with insulin therapy have not been published yet. Evidence concerning the mechanism and the effect of insulin on glucose and lipid metabolism in pediatric critical illness is scarce. More is known about the positive effect on protein homeostasis, especially in severely burned children. The effect in septic children is less clear and seems age dependent. Some non-metabolic properties of insulin such as the modulation of inflammation, endothelial dysfunction and coagulopathy have not been fully investigated in children. Conclusion: Future studies on the effect of insulin on morbidity and mortality as well as on the mechanisms through which insulin exerts these effects are necessary in critically ill children. We propose these studies to be conducted under standardized conditions including precise definitions of hyperglycemia and rates of glucose intake.

KW - Catabolism

KW - Critical illness

KW - Endothelium

KW - Hyperglycemia

KW - Inflammation

KW - Metabolism

KW - Pediatrics

UR - http://www.scopus.com/inward/record.url?scp=36048943947&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36048943947&partnerID=8YFLogxK

U2 - 10.1016/j.clnu.2007.08.012

DO - 10.1016/j.clnu.2007.08.012

M3 - Review article

C2 - 17950500

AN - SCOPUS:36048943947

VL - 26

SP - 677

EP - 690

JO - Clinical Nutrition

JF - Clinical Nutrition

SN - 0261-5614

IS - 6

ER -